Onco-Innovations Limited (CVE:ONCO) | WebDisclosure

Basculer en Français

9480	Companies
185543	Keywords
117939	Articles
99384	Press releases

Headlines Articles Press releases Onco-Innovations Limited

Home
Companies
Onco-Innovations Limited

BRIEF

published on 04/18/2025 at 00:05, 7 months 17 days ago

Onco-Innovations s'associe à Dalton Pharma pour la synthèse de l'isotope PNKP

Recherche Sur Le Cancer Onco-Innovations Technologie PNKP Services Pharmaceutiques Dalton Études ADME
PRESS RELEASE

published on 04/18/2025 at 00:00, 7 months 17 days ago

Onco-Innovations Announces Partnership with Dalton Pharma for Isotope Synthesis of Patented PNKP Technology
Onco-Innovations partners with Dalton Pharma Services to synthesize heavy labelled PNKP inhibitor for increasing survival rate in colorectal cancer mice. Study showcases promising therapeutic potential

Colorectal Cancer Survival Rate Onco-Innovations Dalton Pharma Services PNKP Inhibitor
BRIEF

published on 04/17/2025 at 01:35, 7 months 18 days ago

Onco-Innovations Plans $600,000 Private Placement

Private Placement Warrants Regulatory Approval Securities Offering Corporate Funding
BRIEF

published on 04/17/2025 at 01:35, 7 months 18 days ago

Onco-Innovations prévoit un placement privé de 600 000 $

Placement Privé Offre De Titres Mandats Financement Des Entreprises Approbation Réglementaire
PRESS RELEASE

published on 04/17/2025 at 01:30, 7 months 18 days ago

Onco-Innovations Announces Private Placement
Onco-Innovations Limited announces a non-brokered private placement of up to 400,000 units at $1.50 per unit, for gross proceeds of up to $600,000, with plans for cancer research and treatment advancements

Private Placement Securities Oncology Cancer Research Onco-Innovations Limited
BRIEF

published on 04/11/2025 at 00:05, 7 months 24 days ago

Onco-Innovations' Inka Health Advances Real-World Oncology Research

Clinical Trials Oncology Research Real-world Data Quantitative Bias Analysis Regulatory Assessments
BRIEF

published on 04/11/2025 at 00:05, 7 months 24 days ago

Inka Health, filiale d'Onco-Innovations, fait progresser la recherche en oncologie dans le monde réel.

Essais Cliniques Recherche En Oncologie Données Du Monde Réel Analyse Des Biais Quantitatifs Évaluations Réglementaires
PRESS RELEASE

published on 04/11/2025 at 00:00, 7 months 24 days ago

Onco-Innovations’ Inka Health Publishes Roche-Sponsored Study Advancing Real-World Oncology Research
Onco-Innovations Limited announces groundbreaking study on adjusting bias in real-world oncology research, published in JAMA Network Open, offering a method to enhance clinical comparisons

Bias Analysis Onco-Innovations Limited Real-world Oncology Research JAMA Network Open Clinical Comparisons
BRIEF

published on 04/04/2025 at 00:05, 8 months 1 day ago

Inka Health's Analytical Achievements for AstraZeneca Canada Highlighted at ISPOR 2025

Real-world Evidence Pharmaceutical Analytics ISPOR 2025 Healthcare Decision-Making AstraZeneca Collaboration
BRIEF

published on 04/04/2025 at 00:05, 8 months 1 day ago

Les réalisations analytiques d'Inka Health pour AstraZeneca Canada mises en lumière à l'ISPOR 2025

Preuves Du Monde Réel ISPOR 2025 Analyse Pharmaceutique Prise De Décision En Matière De Soins De Santé Collaboration Avec AstraZeneca

Accesswire

Published on 12/05/2025 at 20:25, 16 minutes ago

The Feedback Loop: Why SMX's Adoption in One Industry Accelerates Interest in All the Others
Published on 12/05/2025 at 20:15, 26 minutes ago

When Proof Becomes Infrastructure, Markets Rewrite the Story (NASDAQ: SMX)
Published on 12/05/2025 at 19:50, 51 minutes ago

Gold, Rare Earth Minerals, Digital Assets: The Market Just Realized SMX Sits in All Three
Published on 12/05/2025 at 19:20, 1 hour 21 minutes ago

The Multi-Sector Validation Shock: Why SMX Became Impossible for Markets to Ignore
Published on 12/05/2025 at 18:45, 1 hour 56 minutes ago

Four Global Markets, One Engine: SMX Just Redefined What a Supply Chain Can Prove

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 18:58, 1 hour 43 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 2 hours 15 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 2 hours 26 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:51, 2 hours 49 minutes ago

Issue of Equity
Published on 12/05/2025 at 17:46, 2 hours 55 minutes ago

Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds

Les Echos

Published on 12/05/2025 at 17:18, 3 hours 23 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 3 hours 23 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 5 hours 30 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 5 hours 30 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 6 hours 43 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE